Bintrafusp alfa Uses, Dosage, Side Effects and more
Bintrafusp alfa is under investigation in clinical trial NCT03833661 (M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)).
| Trade Name | Bintrafusp alfa |
| Generic | Bintrafusp alfa |
| Bintrafusp alfa Other Names | Bintrafusp alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
